ABBV

ABBV

AbbVie Inc
Biotechnology
$272.42 +0.40% As of Oct 9, 2:49 AM
Loading chart...
Interactive chart powered by TradingView

Technical Analysis

Calm Before Storm? ABBV Squeezes at $272.42

Neutral
Oct 9, 2026 at 2:49 AM • $272.42 (+0.40%)

AbbVie Inc (ABBV) gained 0.40% to finish at $272.42 on October 9.

The technical picture is bullish:

Moving Averages Bullish EMA alignment intact with price above the 9-day at $266.88 and 21-day at $264.09.
Momentum RSI at 66.4 is neutral but improving. MACD is bullish (2.83 vs signal 2.24).
Volatility A 20-day TTM Squeeze suggests volatility is coiled and a breakout may be imminent.

The bullish trend is intact, but overbought momentum readings suggest waiting for a pullback.

The $257.67-$271.01 range defines near-term boundaries.

Calm Before Storm? ABBV Squeezes at $272.42

Neutral
Oct 8, 2026 at 9:00 PM • $272.42 (+0.40%)

ABBV Range Contracts Sharply Near $271.36

Neutral
Oct 7, 2026 at 9:00 PM • $271.36 (+1.76%)

ABBV Volatility Compresses at $266.69, Breakout Watch

Neutral
Oct 6, 2026 at 9:00 PM • $266.69 (+0.35%)

Breakout Alert: ABBV Squeeze Intensifies at $265.76

Neutral
Oct 5, 2026 at 9:00 PM • $265.76 (+1.12%)
Systematic technical analysis • Updated daily after market close

Get Trade Alerts

Receive disciplined options trade ideas with entries, targets & risk management.

Subscribe Now Try Scanner

Market Summary

Current Price $272.42
Daily Change +0.40%
Sentiment Neutral
Sector Biotechnology
Last Updated Oct 9

Related Stocks

AMGN
AMGN
Amgen Inc
BIIB
BIIB
Biogen Inc
MRNA
MRNA
Moderna Inc
REGN
REGN
Regeneron Pharmaceuticals Inc
VRTX
VRTX
Vertex Pharmaceuticals Inc
Disclaimer: This analysis is for educational purposes only. Options trading involves substantial risk. Past performance does not guarantee future results.